Section Arrow
ETON.NASDAQ
- Eton Pharmaceuticals
Quotes are at least 15-min delayed:2025/09/14 07:43 EDT
Regular Hours
Last
 17.65
+0.08 (+0.46%)
Day High 
17.85 
Prev. Close
17.57 
1-M High
18.31 
Volume 
169.13K 
Bid
16.51
Ask
18.05
Day Low
17.28 
Open
17.48 
1-M Low
15.6 
Market Cap 
471.18M 
Currency USD 
P/E 124 
%Yield -- 
10-SMA 17.54 
20-SMA 17.22 
50-SMA 15.94 
52-W High 21.48 
52-W Low 4.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.15/1.47
Enterprise Value
501.10M
Balance Sheet
Book Value Per Share
0.89
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
39.01M
Operating Revenue Per Share
1.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.12+0.06+5.66%-- 
IXHLIncannex Healthcare0.5475+0.0175+3.30%-- 
CGCCanopy Growth Corp1.37-0.02-1.44%-- 
VTRSViatris9.96-0.21-2.06%227.2PE
TEVATeva Pharmaceutical Industries Limited19.93+0.04+0.20%-- 
Quotes are at least 15-min delayed:2025/09/14 07:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.